Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: A systematic review

International Journal of COPD

Volumn 9, Issue , 2014, Pages 315-330

  Pooler, Alison ^a,b   Beech, Roger ^a  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Anxiety; COPD; Depression; Exacerbations; Hospital admissions

Indexed keywords

AIRWAY OBSTRUCTION; ANXIETY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EMERGENCY WARD; EXERCISE; GENDER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFORMATION RETRIEVAL; LENGTH OF STAY; LUNG DISEASE; MORTALITY; PATIENT CARE; QUALITY OF LIFE; QUANTITATIVE STUDY; SELF CARE; SOCIAL STATUS; SYSTEMATIC REVIEW; UNITED KINGDOM;

ANXIETY; COPD; DEPRESSION; EXACERBATIONS; HOSPITAL ADMISSIONS;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; COMORBIDITY; DEPRESSION; DISEASE PROGRESSION; HUMANS; LUNG; PATIENT ADMISSION; PATIENT READMISSION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84897511807     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S53255     Document Type: Article

References (60)

1. World Health Organization. World Health Report. Geneva: World Health Organization; 2002. Available from: http://www.who.int/whr/2002. Accessed September 29, 2013.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause, 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498-1504.
3. Department of Health. An Outcomes Strategy for Chronic Obstructive Pulmonary Disease (COPD) and Asthma in England. London: Her Majesty's Stationery Office; 2011. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216139/dh_128428.pdf. Accessed September 29, 2013.
4. Jennings JH, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009;187(2):128-135.
5. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165-1185.
6. Ozkaya S, Findik S, Atici AG. The cost of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease. Clinicoecon Outcomes Res. 2011;3:15-18.
7. Calverley P. PMPA. (1998). COPD; the key facts. London; BLF
8. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613-620.
9. Calderón-Larrañaga A, Carney L, Soljak M, et al. Association of population and primary healthcare factors with hospital admissions rates for chronic obstructive pulmonary disease in England; national cross-sectional study. Thorax. 2011;66(3):191-196.
10. Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group; Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121(5):1449-1455.
11. Roberts CM, Stone RA, Lowe D, Pursey NA, Buckingham RJ. Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD. 2011;8(5):354-361.
12. Royal College of Physicians, British Thoracic Society, British Lung Foundation. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008; Clinical Audit of CopdExacerbations Admitted to Acute NhsUnits Across the Uk. London: The Health Foundation; 2008. Available from: http://www.rcplondon.ac.uk/sites/default/files/report-of-the-national-copd-audit-2008-resources-and-organisation-of-care-in-acute-nhs-units-across-the-uk.pdf. Accessed September 29, 2013.
13. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204-1213; discussion 1213-1215.
14. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786-796.
15. Seemungal TA, Donaldson GC, Bhowmik A, Jefferies DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(5):1608-1613.
16. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10);847-852.
17. Andenaes R, Kalfoss MH, Wahl A. Psychological distress and quality of life in hospitalized patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004;46(5):523-530.
18. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5): 491-496.
19. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414-419.
20. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD; Ambulatory Care Quality Improvement Project Investigators. Using quality of life to predict hospitalisation and mortality in patients with obstructive lung diseases. Chest. 2002;122(2);429-436.
21. Garcia-Aymerich J, Farrera E, Félez MA, Izquierdo J, Marrades RM, Antó JM; Estudi del Factors de Risc d'Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100-105.
22. Peruzza S, Sergi G, Vianello A. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med. 2003;97(6):612-617.
23. Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346-2350.
24. Kunik ME, Roundy K, Veazey C. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4): 1205-1211.
25. Gudmundsson C, Gislason T, Janson C. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87-93.
26. Almagro P, Calbo E, Ochoa de Echagüen A. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441-1448.
27. Centre for Reviews and Dissemination. Systematic Reviews: Crd's Guidance for Undertaking Reviews in Health Care. Layerthorpe: York Publishing Services Ltd; 2009. Available from: http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf. Accessed September 29, 2013.
28. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349.
29. Critical Appraisal Skills Programme. (2013). Retrieved on 19.4.13 from; http://www.casp-uk.net. Accessed September 29, 2013.
30. Pluye P, Robert E, Cargo M, et al. Mixed Methods Appraisal Tool Version 2011. Quebec, Canada: McGill University; 2011. Available from: http://mixedmethodsappraisaltoolpublic.pbworks.com/f/MMAT%202011%20criteria%20and%20tutorial%202011-06-29.pdf. Accessed January 17, 2013.
31. Popay J, Roberts H, Sowden A, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews; A Product from the EsrcMethods Programme. Lancaster, UK: Lancaster University; 2006. Available from: http://www.lancaster.ac.uk/shm/research/nssr/research/dissemination/publications/NS_Synthesis_Guidance_v1.pdf. Accessed September 29, 2013.
32. Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52(5):441-449.
33. Alcázar B, García-Polo C, Herrejón A. Factors associated with hospital admissions for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol. 2012;48(3):70-76. Spanish [with English abstract].
34. Almagro P, Barreiro B, Ochoa de Echaguen A, et al. Risk factors for hospital admissions in patients with chronic obstructive pulmonary disease. Respiration. 2006;73(3):311-317.
35. Cao Z, Ong KC, Eng P, Tan NC, Ng TP. (2006). Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11(2):188-195.
36. Carneiro R, Sousa C, Pinto A, Almeida F, Oliveira JR, Rocha N. Risk factors for readmission after hospital discharge in chronic obstructive pulmonary disease. The role of quality of life indicators. Rev Port Pneumol. 2010;16(5):759-777. Portuguese [with English abstract].
37. Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmissions in COPD patients on early discharge services: a cohort study. BMC Pulm Med. 2011;11:49.
38. Eisner MD, Blanc PD, Yelin EH. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229-234.
39. Gruffydd-Jones K, Langley-Johnson C, Dyer C, Badlan K, Ward S. What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)? Prim Care Respir J. 2007;16(6):363-368.
40. Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009;71(6): 667-674.
41. Maurer J, Rebbapragada V, Borson S, et al; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research areas. Chest. 2008;134(Suppl 4):43S-56S.
42. Quint JK, Baghai-Ravary R, Donaldson GG, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008; 32(1):53-60.
43. Regvat J, Žmitek A, Vegnuti M, Košnik M, Šuškovič S. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2011;39(3):1028-1038.
44. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913-920.
45. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital admission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60-67.
46. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2010;41(6):465-471.
47. Fan VS, Ramsey SD, Giardino ND, et al; National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(21):2345-2353.
48. Bailey PH. The dyspnea-anxiety-dyspnea cycle: COPD patients' stories of breathlessness: "It's scary when you can't breathe". Qual Health Res. 2004;14(6):760-778.
49. Nicolson P, Anderson P. The patient's burden; physical and psychological effects of acute exacerbations of chronic bronchitis. J Antimicrob Chemother. 2000;45:25-32.
50. Soler JJ, Sánchez L, Román P, Martínez MA, Perpiñá M. Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. Respir Med. 2004;98(4):318-329.
51. Chen YJ, Narsavage GL. Factors related to chronic obstructive pulmonary disease readmissions in Taiwan. West J Nurs Res. 2006;28(1):105-124.
52. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65-70.
53. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993-1013.
54. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688-692.
55. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278-3285.
56. Felker B, Katon W, Hendrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23(2):56-61.
57. Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch Intern Medicine. 2002;162(16):1860-1866.
58. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Medicine. 2000;160(14):2101-2107.
59. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154-2160.
60. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293-299.